Similar articles

• Intensive leukapheresis as initial therapy for chronic granulocytic leukemia.

  Lowenthal RM, Buskard NA, Goldman JM, Spiers AS, Bergier N, Graubner M, Galton DA. Lowenthal RM, et al. Blood. 1975 Dec;46(6):835-44. Blood. 1975. PMID: 1060470
• Response to chronic leukapheresis procedures and survival of chronic myelogenous leukemia patients.

  Hester JP, McCredie KB, Freireich EJ. Hester JP, et al. Transfusion. 1982 Jul-Aug;22(4):305-7. doi: 10.1046/j.1537-2995.1982.22482251215.x. Transfusion. 1982. PMID: 6179267
• Leukapheresis of patients with chronic granulocytic leukemia (CGL), using the Haemonetics blood processor.

  Huestis DW, Price MJ, White RF, Inman M. Huestis DW, et al. Transfusion. 1976 May-Jun;16(3):255-60. doi: 10.1046/j.1537-2995.1976.16376225500.x. Transfusion. 1976. PMID: 59435
• Current concepts in chronic myelogenous leukemia.

  Stryckmans PA. Stryckmans PA. Semin Hematol. 1974 Apr;11(2):101-27. Semin Hematol. 1974. PMID: 4595812 Review. No abstract available.
• [Leukopoietins].

  Kakhetelidze MG. Kakhetelidze MG. Patol Fiziol Eksp Ter. 1974 Sep-Oct;14(5):83-91. Patol Fiziol Eksp Ter. 1974. PMID: 4599043 Review. Russian. No abstract available.